⌘K

Tempest Therapeutics, Inc. (TPST)

$1.41 0.00% $0.00 Healthcare

Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial in solid tumors. It also develops TREX-1, a key cellular enzyme that regulates the innate immune response in tumors. The company was founded in 2011 and is headquartered in South San Francisco, California. Tempest Therapeutics Inc. was formerly a subsidiary of Inception Sciences, Inc.

Market cap

$35.54M

CEO

Mr. Stephen R. Brady J.D., LLM

Full time employees

17.00

Headquarters

South San Francisco, CA

IPO Date

Jun 24, 2021

Price-to-earnings (PE) Ratio

-0.88

Earnings-per-share (EPS)

$-1.60

Cash ratio (TTM)

2.04

Current ratio (TTM)

2.15

Net profit margin (TTM)

0.00%

PE ratio (TTM)

-1.57

PEG ratio (TTM)

0.02

Price-to-book ratio (TTM)

10.86

Price-to-sales ratio (TTM)

0.00

Quick ratio (TTM)

2.04

Return on assets (TTM)

-112.99%

Return on equity (TTM)

-228.29%

Similar stocks (17)

Revolution Medicines, Inc.

RVMD

$46.18 4.81% $2.12

Uptrend

Cullinan Oncology, Inc.

CGEM

$17.94 4.12% $0.71

Downtrend

Sana Biotechnology, Inc.

SANA

$4.62 7.69% $0.33

Downtrend

Olema Pharmaceuticals, Inc.

OLMA

$13.60 6.17% $0.79

Neutral

Lyell Immunopharma, Inc.

LYEL

$1.56 15.56% $0.21

Downtrend

Monte Rosa Therapeutics, Inc.

GLUE

$6.25 5.04% $0.30

Neutral

Rezolute, Inc.

RZLT

$4.82 -1.03% $-0.05

Uptrend

Ikena Oncology, Inc.

IKNA

$1.71 3.01% $0.05

Neutral

Armata Pharmaceuticals, Inc.

ARMP

$2.23 6.19% $0.13

Downtrend

Anebulo Pharmaceuticals, Inc.

ANEB

$2.08 4.00% $0.08

Downtrend

Akari Therapeutics, Plc

AKTX

$3.16 -1.86% $-0.06

Neutral

RenovoRx, Inc.

RNXT

$0.98 -0.61% $-0.00

Downtrend

Indaptus Therapeutics, Inc.

INDP

$1.50 6.38% $0.09

Downtrend

Forte Biosciences, Inc.

FBRX

$7.00 4.09% $0.28

Downtrend

Processa Pharmaceuticals, Inc.

PCSA

$1.37 -3.52% $-0.05

Downtrend

Comera Life Sciences Holdings, Inc.

CMRA

$0.02 0.00% $0.00

Downtrend

Scopus BioPharma Inc.

SCPS

$0.00 0.00% $0.00

Downtrend

ETF Exposure (4)

iShares Micro-Cap ETF

IWC

0.00575%

$126.54 2.19% $2.71

Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

2.776e-5%

$34.14 1.82% $0.61

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$138.77 2.02% $2.75

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.92 2.00% $3.58

Uptrend

Downtrend

Similar stocks (17)

Revolution Medicines, Inc.

RVMD

$46.18 4.81% $2.12

Uptrend

Cullinan Oncology, Inc.

CGEM

$17.94 4.12% $0.71

Downtrend

Sana Biotechnology, Inc.

SANA

$4.62 7.69% $0.33

Downtrend

Olema Pharmaceuticals, Inc.

OLMA

$13.60 6.17% $0.79

Neutral

Lyell Immunopharma, Inc.

LYEL

$1.56 15.56% $0.21

Downtrend

Monte Rosa Therapeutics, Inc.

GLUE

$6.25 5.04% $0.30

Neutral

Rezolute, Inc.

RZLT

$4.82 -1.03% $-0.05

Uptrend

Ikena Oncology, Inc.

IKNA

$1.71 3.01% $0.05

Neutral

Armata Pharmaceuticals, Inc.

ARMP

$2.23 6.19% $0.13

Downtrend

Anebulo Pharmaceuticals, Inc.

ANEB

$2.08 4.00% $0.08

Downtrend

Akari Therapeutics, Plc

AKTX

$3.16 -1.86% $-0.06

Neutral

RenovoRx, Inc.

RNXT

$0.98 -0.61% $-0.00

Downtrend

Indaptus Therapeutics, Inc.

INDP

$1.50 6.38% $0.09

Downtrend

Forte Biosciences, Inc.

FBRX

$7.00 4.09% $0.28

Downtrend

Processa Pharmaceuticals, Inc.

PCSA

$1.37 -3.52% $-0.05

Downtrend

Comera Life Sciences Holdings, Inc.

CMRA

$0.02 0.00% $0.00

Downtrend

Scopus BioPharma Inc.

SCPS

$0.00 0.00% $0.00

Downtrend

ETF Exposure (4)

iShares Micro-Cap ETF

IWC

0.00575%

$126.54 2.19% $2.71

Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

2.776e-5%

$34.14 1.82% $0.61

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$138.77 2.02% $2.75

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.92 2.00% $3.58

Uptrend